Nektar Therapeutics
NKTR
NKTR
181 hedge funds and large institutions have $1.73B invested in Nektar Therapeutics in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
18% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 45
Holders
181
Holding in Top 10
2
Calls
$6.54M
Puts
$4.74M
Top Buyers
| 1 | +$55.3M | |
| 2 | +$42.8M | |
| 3 | +$18.8M | |
| 4 |
GAM
Gotham Asset Management
New York
|
+$17.1M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$15.4M |
Top Sellers
| 1 | -$44.8M | |
| 2 | -$14.4M | |
| 3 | -$12.4M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.42M |
| 5 |
DFO
Duquesne Family Office
New York
|
-$7.21M |